6505-01-340-4829 ( NDC00182-8229-89 , NDC00591-0747-01 , NDC51079-0882-01 , NDC00378-1912-01 , NDC00904-5343-60 , NDC60505-0067-01 , NDC00228-3004-11 , NDC00093-0833-01 , NDC57664-0274-08 , NDC00185-0064-01 , NDC00004-0058-01 , NDC51079-0882-21 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-340-4829 | 6505 | 013404829 | CLONAZEPAM TABLETS,USP | 3395 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| FEAT | SPECIAL FEATURES | UNIT DOSE; REVERSE NUMBER PACK |
| EXME | EXTERIOR CONTAINER CUBIC MEASURE | 0.77 CUBIC FEET |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CLONAZEPAM TABLETS USP 1MG I.S. 100S PG |
| SUCB | UNIT OF ISSUE CUBE | 0.012 CUBIC FEET |
| ECWT | EXTERIOR CONTAINER WEIGHT | 8.50 POUNDS |
| AJCN | PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 25.000 TABLETS |
| CQCT | PRIMARY CONTAINER TYPE | STRIP, REVERSE NUMBERED |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.000 MILLIGRAMS CLONAZEPAM ACTIVE INGREDIENT |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 4 |
| PKTY | UNIT PACKAGE TYPE | BOX |
| CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC00182-8229-89 | 63488 | A | 2 | 3 | 4 | ZZ | |
| NDC00591-0747-01 | 62051 | A | 2 | 5 | 4 | ZZ | |
| NDC51079-0882-01 | 65751 | A | 2 | 3 | 4 | ZZ | |
| NDC00378-1912-01 | 60895 | A | 1 | 5 | 4 | ZZ | |
| NDC00904-5343-60 | 0SYT3 | A | 2 | 5 | 4 | ZZ | |
| NDC60505-0067-01 | 1VZL6 | A | 2 | 5 | 4 | ZZ | |
| NDC00228-3004-11 | 56287 | A | 2 | 5 | 4 | ZZ | |
| NDC00093-0833-01 | 80608 | A | 2 | 5 | 4 | ZZ | |
| NDC57664-0274-08 | 0PUV4 | A | 2 | 5 | 4 | ZZ | |
| NDC00185-0064-01 | 0WTU2 | A | 2 | 5 | 4 | ZZ | |
| NDC00004-0058-01 | 04493 | A | 1 | 5 | 4 | ZZ | |
| NDC51079-0882-21 | 65751 | A | 2 | 5 | 4 | ZZ |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC00182-8229-89 | 63488 | GOLDLINE LABORATORIES INC. | A | A |
| NDC00591-0747-01 | 62051 | DANBURY PHARMACAL INC | A | A |
| NDC51079-0882-01 | 65751 | UDL LABORATORIES, INC. | A | A |
| NDC00378-1912-01 | 60895 | MYLAN PHARMACEUTICALS INC | A | A |
| NDC00904-5343-60 | 0SYT3 | MAJOR PHARMACEUTICALS INC | F | A |
| NDC60505-0067-01 | 1VZL6 | FALCON PHARMACEUTICALS LTD | F | A |
| NDC00228-3004-11 | 56287 | ACTAVIS INC | A | A |
| NDC00093-0833-01 | 80608 | LEMMON CO | A | A |
| NDC57664-0274-08 | 0PUV4 | CARACO PHARMACEUTICAL LABORATORI | A | A |
| NDC00185-0064-01 | 0WTU2 | EON LABS INC. | A | A |
| NDC00004-0058-01 | 04493 | HOFFMANN-LA ROCHE INC. | F | A |
| NDC51079-0882-21 | 65751 | UDL LABORATORIES, INC. | A | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | X | A | 1 | 06/13/1 | P | 3004909130 | 3395 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| DA | C2201X- | A | K | U/I CONTAINS 100 TT | |
| DS | I | K | U/I CONTAINS 100 TT | ||
| DS | I | V | DISCONTINUED W/O REPLACEMENT | ||
| DN | 9B----- | N | K | U/I CONTAINS 100 TT | |
| DA | C2201X- | A | V | DISCONTINUED W/O REPLACEMENT | |
| DN | 9B----- | N | V | DISCONTINUED W/O REPLACEMENT |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | A | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| DA | SMS | Y | 1 | PG | M | Q | C2201X- | A | |
| DS | SMS | Y | 1 | PG | M | Q | D | ||
| DN | SMS | Y | 1 | PG | M | Q | 9B----- | N |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|---|---|---|---|
| C | 2 | 2 | 01 | X |
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|